Metabolic risk factors for cardiovascular disease in a working population: A retrospective cohort study

Journal of Clinical Epidemiology

Volumn 49, Issue 3, 1996, Pages 267-271

  Gumbiner, Barry ^a,b   Andresen, Elena M ^a   Hearne, F Terry ^c   Michaelson, T Erik ^a   Bryson, Michael ^a,c   Lednar, Wayne M ^a,c   Cass, Roger ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b Monroe Community Hospital   (United States)

^c EASTMAN KODAK COMPANY   (United States)

Author keywords

Diabetes; Epidemiology; Hyperlipidemia; Hypertension; Insulin resistance; Metabolism; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LABORATORY TEST; LIPID BLOOD LEVEL; MALE; METABOLISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0029933268     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00561-7     Document Type: Article

References (35)

1. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-308.
2. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3H-9H.
3. Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertension 1994; 7: 7S-12S.
4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312-328.
5. Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann Epidemiol 1992; 2: 77-83.
6. Hames CG, Rose K, Knowles M, Davis CE, Tyroler HA. Black-white comparisons of 20-year coronary heart disease mortality in the Evans County Heart Study. Cardiology 1993; 82: 122-136.
7. Reaven GM. Role of insulin resistance in human disease: Banting Lecture. Diabetes 1988; 37: 1595-1607.
8. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
9. Olefsky JM, Molina JM. Insulin resistance in man. In: Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice. Rifkin H, Porte D (eds). New York: Elsevier; 1990: 121-154.
10. Ferrannini E, Buzzigulo G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
11. Steiner G. Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. Am J Cardiol 1986; 57: 27G-30G.
12. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-146.
13. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL cholesterol, triglyceride and insulin concentrations. J Int Med 1992; 231: 25-30.
14. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15 year follow-up. Diabetologia 1991; 34: 356-361.
15. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
16. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 1992; 41: 715-722.
17. Olefsky, J. Obesity. In Isselbacher KJ, Brownwald E, Wilson JD, Martin JB, Fauci AS, Kaspar DL (eds). Harrisons Principles of Internal Medicine, 13th ed. New York: McGraw-Hill; 1994; 446-452.
18. Lasky FD. Achieving accuracy for routine clinical chemistry methods by using patient specimen correlations to assign calibrator values. Arch Pathol Med 1993; 117: 412-419.
19. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
21. Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-39.
22. Consensus Conference. Treatment of hypertriglyceridemia. JAMA 1984; 251: 1196-1200.
23. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension detection and follow-up program. Prev Med 1976; 5: 207-215.
24. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley and Sons; 1981; 14-17.
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 273: E214-E223.
26. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Company; 1986; 91-92.
27. Burchfield CM, Shetterly SM, Baxter J, Hamman RF. The roles of insulin, obesity, and fat distribution in the elevation of cardiovascular risk factors in impaired glucose tolerance. The San Luis Valley diabetes study. Am J Epidemiol 1992; 136: 1101-1109.
28. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
29. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 1988-1992.
30. Fontebonne A, Papoz L, Eschwege E, Roger M, Saint-Paul M, Simon D. Features of insulin-resistance syndrome in men from French Caribbean islands. Diabetes 1992; 41: 1385-1389.
31. Fontebonne A, Eschwege E. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 1991; 14: 461-469.
32. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents. The Bogalusa Heart Study. Am J Hypertens 1993; 6: 564-569.
33. Raitakari OT, Porkka KV, Viikari JS, Ronnemaa T, Akerblom HK. Clustering of risk factors for coronary heart disease in children and adolescents. The Cardiovascular Risk in Young Finns Study. Acta Paediatr 1994; 83: 935-940.
34. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14; 1132-1143.
35. Checkoway H, Pearce N, Crawford-Brown DJ. Research Methods in Occupational Epidemiology. New York: Oxford University Press; 1989; 78-79, 136.